| __timestamp | Alpine Immune Sciences, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 13673000 |
| Thursday, January 1, 2015 | 16054000 | 14358000 |
| Friday, January 1, 2016 | 23316000 | 12203000 |
| Sunday, January 1, 2017 | 10626000 | 18125000 |
| Monday, January 1, 2018 | 28970000 | 17071000 |
| Tuesday, January 1, 2019 | 35847000 | 20018000 |
| Wednesday, January 1, 2020 | 27185000 | 32788000 |
| Friday, January 1, 2021 | 58742000 | 44966000 |
| Saturday, January 1, 2022 | 70243000 | 311681000 |
| Sunday, January 1, 2023 | 80904000 | 77707000 |
Unleashing insights
In the ever-evolving landscape of biotechnology and pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and Lantheus Holdings, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Alpine Immune Sciences, Inc. increased its R&D expenses by over 560%, reflecting a robust commitment to pioneering new therapies. In contrast, Lantheus Holdings, Inc. experienced a more volatile R&D spending pattern, with a significant spike in 2022, where expenses surged by over 600% compared to the previous year. This fluctuation highlights Lantheus's strategic focus on targeted innovation bursts.
As these companies navigate the competitive biotech sector, their R&D investments will continue to shape their future trajectories, offering insights into their strategic priorities and market positioning.
R&D Spending Showdown: Amgen Inc. vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.